Abstract
Objective To investigate the expression and clinical significance of estrogen receptor (ER) ,progesterone receptor (PR), HER-2 and p53 in endometrial carcinoma. Methods The immunohis-tostaining of 162 cases of endometrial carcinoma was detected for ER, PR, HER-2 and 1053 expression, and the relationship between histological grade, depth of invasion and lymph node metastasis was analyzed. Results In 162 cases of endometrial carcinoma, the positive rate of ER, PR, HER2 and p53 was 53.7% ,61.1%, 18.5% and 33. 3% ,respectly. The expression of ER and PR was related to the histological grade or endometrial adeno-carcinoma,but without relationship to the invnsive depth and lymph node metastasis. The expression of HER-2 and p53 was related the invasive depth, and HER-2 expression was related lymph node metastasis. Conclusion The detection of ER, PR, HER-2 and p53 expression in endometrial carcinoma helped to access the prognosis and formulate individualized treatment programs. Key words: Endometrial cancer; Estrogen receptor; progesterone receptor; HER-2 ; p53 ; Immunohistechemistry
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
